Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of RTS Group on its sale to Advania Bryan, Garnier & Co acts as Sole Financial Advisor to Vulcain Engineering on the acquisition of iPlan Gestión Integral Bryan, Garnier & Co acts as Sole Financial Advisor to Canon on the sale of Canon France Business Services to Paragon Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on Median Technologies’ EUR 21.6 million Follow-On Offering & Convertible Bonds Issuance Bryan, Garnier & Co acts as Sole Financial Advisor to PhysioAssist on its $45m Sale to Inogen Bryan, Garnier & Co acts as Sole Financial Advisor to Physidia and its shareholders, a leading European renal care medtech company providing home haemodialysis solutions, on the sale of a majority stake to Columna Capital Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Medincell’s EUR 25 million Follow-on Offering Bryan, Garnier & Co acts as the sole financial advisor to the shareholders of Tinqin on their recent sale to be ys Bryan, Garnier & Co acts as Financial Advisor & Placement Agent on Abivax’s EUR 130 million Cross-over Financing Bryan, Garnier & Co acts as Sole Financial Advisor to Mint Media and its shareholders on the sale of Mint Media to Aleven Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Egetis Therapeutics’ Nasdaq Stockholm SEK 210 million Follow-on Offering Bryan, Garnier & Co acts as Sole Financial Advisor to Selfapy, one of the leading providers in digital therapeutics for mental health disorders in Germany, on its growth financing from strategic investor Medice Arzneimittel and existing shareholders
